STANLEY SOLES: Open Payments
NPI 1750790465 · ADEL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$147 in 7 payments from 7 companies in 2025. Trend: 2023 $424 · 2024 $204 · 2025 $147
Food & beverage: $147
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: LYBALVI, REXULTI, Qelbree, AUSTEDO XR, VRAYLAR, COBENFY, Auvelity.
Industry payments across GA — which companies pay providers there.
